| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Caleb DesRosiers is Director at DXR. Caleb DesRosiers's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $28K at current prices.
Net of sales, the DXR filings show accumulation of 3,157 shares.
Caleb DesRosiers has 6 Form 4 filings on record from June 2022 to June 2026, all as Director at Daxor (DXR), 2022–2026.
The 6 reported transactions were 5 option or other derivative awards and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $30K and no sales.
The only open-market purchase was 3,157 shares of DXR at an average $9.50 on November 17, 2022, about $30K. Twelve months later DXR was down 25%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 | DXR Daxor Corp | Director | Buy | 3,157 | $9.50 | $29,991.50 | New | -11.8% | -24.5% |